GB1250394A - - Google Patents

Info

Publication number
GB1250394A
GB1250394A GB1250394DA GB1250394A GB 1250394 A GB1250394 A GB 1250394A GB 1250394D A GB1250394D A GB 1250394DA GB 1250394 A GB1250394 A GB 1250394A
Authority
GB
United Kingdom
Prior art keywords
steroids
formula
group
alkanoyloxy
jan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN118263A external-priority patent/IN118263B/en
Application filed filed Critical
Publication of GB1250394A publication Critical patent/GB1250394A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

1,250,394. 3 - Cyclopentyloxy - #<SP>1,3,5(10)</SP>- steroids. AMERICAN HOME PRODUCTS CORP. 23 Jan., 1969 [23 Jan., 1968 ; 24 Oct., 1968], No. 3867/69. Heading C2U. Novel steroids of the formula and their racemates wherein X is (in which R<SP>1</SP> is CH 3 or C 2 H 5 , Z is CO or CH- (#-OH), R is C 1-8 alkyl, ethynyl or chlorethynyl, and R<SP>2</SP> is C 1-8 alkanoyloxy) are prepared (1) by reduction of steroids of the formula in which the #<SP>14</SP> double bond is optional to give, depending on the conditions, a #<SP>1,3,5(10)-8</SP>- tetraener, a #<SP>1,3,5(10)</SP>-triene or an 8-iso- #<SP>1,3,5(10)</SP>-triener; or (2) by etherification with an agent containing a cyclopentyl group of a steroid of the formula wherein X<SP>1</SP> is as X above or is and, if desired or required, oxidizing a resulting 17-ol to a 17-one, reducing a 17-one to a 17-ol with or without concomitant introduction of a 17α-R group, enolacylating a 17-one to a #<SP>16</SP>-17- alkanoyloxy compound, or oxidizing a #<SP>16</SP>-17- alkanoyloxy compound to a 16α-hydroxy-17- ketone or a 16α,17-diol. In these procedures a 17-keto group or a 16- or 17-OH group may be initially protected and subsequently released. These processes may be effected on racemic steroids to give racemic products which may subsequently be resolved, or on optically active steroids. Steroids of the Formula (I) where X has the structure (A), (C), (E) or (F) have estrogenic activity and may be made up into pharmaceutical compositions with suitable carriers.
GB1250394D 1968-01-23 1969-01-23 Expired GB1250394A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69978568A 1968-01-23 1968-01-23
IN118263A IN118263B (en) 1968-10-24 1968-10-24

Publications (1)

Publication Number Publication Date
GB1250394A true GB1250394A (en) 1971-10-20

Family

ID=26324078

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1250394D Expired GB1250394A (en) 1968-01-23 1969-01-23

Country Status (1)

Country Link
GB (1) GB1250394A (en)

Similar Documents

Publication Publication Date Title
GB1151404A (en) Novel Gona-1,3,5(10)-Trienes, Processes for their Preparation, and Compositions incorporating them
GB1494097A (en) D-homo-20-keto-pregnanes
GB1502635A (en) Process for splitting steroid ethers
GB1495531A (en) 11beta-alkyl steroids of the estrane series
ES409653A1 (en) Reducing cholesterol levels with sitosterols and cholanic acid derivatives
GB1250394A (en)
GB1504410A (en) 11beta-fluoroandrostenes
ES457968A1 (en) Novel corticoid * preparation thereof and antiiinflamatory pharmaceutical agent containing the same
GB1514621A (en) 13-ethynyl-and 13-(2-halovinyl)-steroids and their preparation
GB1273025A (en) 07alpha-(2&#39;,3&#39;-BUTADIEN-2&#39;-YL)-ESTR-4-EN-17beta-OL-3-ONE
GB1235768A (en) 6,7 - methylene - 20 - spiroxanes
ES290864A1 (en) Novel steroid esters, their preparation and employment
GB1383334A (en) 15alpha,16alpha-methylene-steroids
GB1164705A (en) Preparation of Delta&lt;7&gt;-Dehydro Steroids
GB1214507A (en) 03-alkyl-11-oxygenated-gonenes
GB1185381A (en) 05,16beta-Methylene Steroids of the 19-Nor-Androstane Series and Process for their Manufacture
GB1512761A (en) Estra-1,3,5,(10)-triene a process for its preparation and pharmaceutical compositions containing it
GB1323383A (en) Pregna-4,9-diene processes for its preparation and compositions thereof
GB1301808A (en)
GB1269291A (en) Improvements in or relating to corticoid carbonates
GB1378168A (en) 6alpha-fluoro-16alpha,18-dimethyl-delta1,4-pregnadiene-3,20-diones
GB1282520A (en) 06-methyl-steroids and processes for their preparation
GB1285263A (en) IMPROVEMENTS IN OR RELATING TO 6alpha,6beta-DIFLUORO STEROIDS
GB1377975A (en) 17alpha-hydroxy-16alpha,18-dimethyl-delta4-pregnene-3,20-dione and its esters
GB1324612A (en) Epoxy estranes processes for their preparation and compositions incorporating them

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years